Results 241 to 250 of about 59,025 (322)

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti   +7 more
wiley   +1 more source

Associations between the measures of physical function, the risk of falls and nutritional status of haemodialysis patients : a cross-sectional study [PDF]

open access: yes, 2019
Calders, Patrick   +6 more
core  

Assessment of genetically modified soybean GMB151 × DAS‐44406‐6 (application GMFF‐2024‐21774, EFSA‐Q‐2024‐00330)

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract Genetically modified soybean GMB151 × DAS‐44406‐6 was developed by crossing to combine two single events: GMB151 and DAS‐44406‐6. The two‐event stack soybean expresses the Cry14Ab‐1, HPPD‐4, PAT, AAD‐12 and 2mEPSPS proteins to confer herbicide tolerance and resistance to plant parasitic nematodes.
EFSA Panel on Genetically Modified Organisms (GMO)   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy